Director/PDMR Shareholding (Replacement)

RNS Number : 7997D

GlaxoSmithKline PLC

21 May 2012

 



This announcement replaces the original announcement released on 11 May 2012 at 15.25 (RNS No: 2041D)

Due to an administrative error by the Administrators of the US Retirement Savings Plan (The Plan), the change in one of the under-mentioned Persons' notional allocation of American Depositary Shares (ADSs) indicated with an asterisk (*) below, was incorrectly stated in the announcement made on 11 May 2012.

Save as disclosed above, all other details remain unchanged. The full amended text is shown below.

 Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

Following a revaluation of the cash element of the notional investment held within the US Retirement Savings Plan (The Plan), which is notionally held in GSK American Depositary Shares (ADSs), the Administrators of the Plan notified GlaxoSmithKline plc and the under-mentioned Persons on 11 May 2012 of an increase in the notional allocation of ADSs on 10 May 2012 at a price of $45.50 per ADS:-

Director/PDMR	Number of ADSs			Connected Person	Number of ADSs
Dr M M Slaoui	11			Dr K Slaoui	9
Mr W C Louv	16			-	-
Dr D Pulman	29			-	-
Mr E J Gray	22*			-	-
Mrs D P Connelly	1			-	-

This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a) and (c).

V A Whyte

Company Secretary

11 May 2012

 

END

 

 

RDSEAXSFAFNAEFF